Skip to main content

Table 5 Types of adverse events reported by patients (N = 92; 264 treatments)

From: Comparison of tolerability and efficacy of a combination of paracetamol + caffeine and sumatriptan in the treatment of migraine attack: a randomized, double-blind, double-dummy, cross-over study

 

Total (n = 264)

Treatment

Fisher exact test (p)

PCF (n = 131)

SUM (n = 133)

N

%

N

%

N

%

None

125

47.3

69

52.7

56

42.1

 

Nervousness

32

12.2

13

10.0

19

14.3

0.4125

Palpitazion

27

10.4

12

9.1

15

11.6

0.6607

Insomnia

11

4.1

6

4.5

5

3.6

0.7471

Dizziness

12

4.5

4

2.7

8

6.3

0.3326

Abdominal pain

12

4.5

3

1.8

9

7.1

0.1016

Dyspepsia

21

8.1

11

7.4

12

8.9

0.8067

Nausea

67

25.2

37

28.2

30

22.3

0.3553

Vomito

6

2.3

4

2.7

2

1.8

0.6818

Drowsiness

42

15.8

18

13.6

24

17.9

0.4625

Fatigue

27

10.4

7

5.5

20

15.1

0.0260